Cancer Immunotherapy: Bridging Basic Research and Clinical Translation

Jan 24–27, 2027 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers: Ana Carrizosa Anderson, Drew M. Pardoll, Neta Erez, and Ivan Diaz-Padilla

  In Person
  On Demand
×

-

Jan 24–27, 2027 | Beaver Run Conference Center, Breckenridge, CO, United States

Scientific Organizers: Ana Carrizosa Anderson, Drew M. Pardoll, Neta Erez, and Ivan Diaz-Padilla

Supported by the  Directors' Fund
Important Deadlines
Early Registration Deadline: Deadlines not yet available for this meeting.
Scholarship Deadline: Deadlines not yet available for this meeting.
Short Talk Abstract Deadline: Deadlines not yet available for this meeting.
Poster Abstract Deadline: Deadlines not yet available for this meeting.
Meeting Summary
#  Cancer

This conference will gather immunologists, oncologists, technologists, and engineers from academia and industry focused on basic research and clinical translation with the goal of fostering interactions among stakeholders that do not normally interact. To achieves this the conference program will feature new approaches targeting innate cells, application of model systems that replicate aspects of human cancer to inform new therapeutic approaches, the application of protein engineering and materials science to bridge gaps in treatment along with the latest innovations regarding T cell state regulation and application of checkpoint therapy in the clinic.

Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates